Drug-Induced Gingival Overgrowth-Molecular Aspects of Drug Actions

被引:14
|
作者
Drozdzik, Agnieszka [1 ]
Drozdzik, Marek [2 ]
机构
[1] Pomeranian Med Univ, Dept Interdisciplinary Dent, Powstancow Wlkp 72, PL-70111 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Pharmacol, Powstancow Wlkp 72, PL-70111 Szczecin, Poland
关键词
gingival overgrowth; drug-induced gingival overgrowth; gingiva; drug side effects; TISSUE GROWTH-FACTOR; CALCIUM-CHANNEL BLOCKERS; CYCLOSPORINE-A; CONNECTIVE-TISSUE; ANGIOTENSIN-II; CATHEPSIN-L; LYSYL OXIDASE; IMMUNOHISTOCHEMICAL ANALYSIS; RECEPTOR EXPRESSION; CELL-PROLIFERATION;
D O I
10.3390/ijms24065448
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug-induced gingival overgrowth (DIGO) is one of the side effects produced by therapeutic agents, most commonly phenytoin, nifedipine and cyclosporin A. However, the precise mechanism of DIGO is not entirely understood. A literature search of the MEDLINE/PubMed databases was conducted to identify the mechanisms involved in DIGO. The available information suggests that the pathogenesis of DIGO is multifactorial, but common pathogenic sequelae of events emerge, i.e., sodium and calcium channel antagonism or disturbed intracellular handling of calcium, which finally lead to reductions in intracellular folic acid levels. Disturbed cellular functions, mainly in keratinocytes and fibroblasts, result in increased collagen and glycosaminoglycans accumulation in the extracellular matrix. Dysregulation of collagenase activity, as well as integrins and membrane receptors, are key mechanisms of reduced degradation or excessive synthesis of connective tissue components. This manuscript describes the cellular and molecular factors involved in the epithelial-mesenchymal transition and extracellular matrix remodeling triggered by agents producing DIGO.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Molecular and Clinical Aspects of Drug-induced Gingival Overgrowth
    Trackman, P. C.
    Kantarci, A.
    JOURNAL OF DENTAL RESEARCH, 2015, 94 (04) : 540 - 546
  • [2] Molecular Aspects of Drug-Induced Gingival Overgrowth: An In Vitro Study on Amlodipine and Gingival Fibroblasts
    Lauritano, Dorina
    Lucchese, Alberta
    Di Stasio, Dario
    Della Vella, Fedora
    Cura, Francesca
    Palmieri, Annalisa
    Carinci, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (08)
  • [3] DRUG-INDUCED GINGIVAL OVERGROWTH
    SEYMOUR, RA
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1993, 12 (04): : 215 - 232
  • [4] Drug-Induced Gingival Overgrowth
    Nakib, Nuha
    Ashrafi, Seema S.
    DM DISEASE-A-MONTH, 2011, 57 (04): : 225 - 230
  • [5] DRUG-INDUCED GINGIVAL OVERGROWTH
    DONGARI, A
    MCDONNELL, HT
    LANGLAIS, RP
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1993, 76 (04): : 543 - 548
  • [6] The management of drug-induced gingival overgrowth
    Mavrogiannis, M
    Ellis, JS
    Thomason, JM
    Seymour, RA
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2006, 33 (06) : 434 - 439
  • [7] The pathogenesis of drug-induced gingival overgrowth
    Seymour, RA
    Thomason, JM
    Ellis, JS
    JOURNAL OF CLINICAL PERIODONTOLOGY, 1996, 23 (03) : 165 - 175
  • [8] Drug-induced gingival overgrowth - a review
    Kataoka, M
    Kido, J
    Shinohara, Y
    Nagata, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (10) : 1817 - 1821
  • [9] Drug-induced gingival overgrowth in cardiovascular patients
    Bajkovec, Lucija
    Mrzljak, Anna
    Likic, Robert
    Alajbeg, Ivan
    WORLD JOURNAL OF CARDIOLOGY, 2021, 13 (04): : 68 - 75
  • [10] NEUROCHEMICAL MARKERS IN DRUG-INDUCED GINGIVAL OVERGROWTH
    LINDEN, GJ
    JAMES, J
    JOHNSTON, C
    JOURNAL OF DENTAL RESEARCH, 1995, 74 (03) : 949 - 949